Sep 17, 2026
Experimental drug targets mesothelioma by disabling cancer's antioxidant defenses
Scientists are testing a new approach to fight mesothelioma by developing an experimental drug that kills cancer cells by disabling PRX3, an antioxidant defense mechanism that tumors use to survive oxidative stress. The counterintuitive treatment targets the aggressive asbestos-linked cancer, which currently has few effective treatment options.
1 source
00